Loading…
Compounded-GLP-1 telehealth marketing gets the hardest first-pass review we cover. Paste the creative and see which phrase trips FTC §5, the FDA compounding line or Meta’s pharmacy policy, and the rewrite that keeps the hook.
Judged against the regulator (FTC) and Meta’s ad policy. Sign in to check other markets.
Between 20 and 2000 characters.
1 free check now · 8 more after sign-up · no card
FTC §5 + Endorsement Guides (2023)
FDA compounding posture (21 USC §503A + Sept 9 2025 100-letter wave)
State pharmacy + telehealth-practice rules
Meta Rx/pharmacy policy + personal-health standards
Pack covers compounded-GLP-1 telehealth-service-marketing. Direct Rx product marketing (Wegovy/Zepbound brand DTC) — V1+ with deeper FDA DTCPA analysis. The active pack is for the telehealth-service slice only.
Not a risk score. The specific words that break the rule, highlighted in your copy.
Approved rewrites that keep the hook. One variant at a time — ask for another if it isn't the one.
Stop losing impressions to rejections you could've caught before you spent a cent.
Three plans, same classifier, same depth on every check. Volume is the only thing that changes between Operator and Studio.
Built by people who've run the ads, not a compliance desk reading rules. A working tool, not a guarantee: every finding cites the policy line we matched, and every override is logged, so you decide what to run.